Latigo Biotherapeutics
All
Newsflash
Article
-
Latigo Biotherapeutics (LTGO) completes IPO, raising nearly $350 million, with its non-opioid pain drug LTG-001 showing 50% greater relief than hydrocodone in trials.
The clinical-stage biopharmaceutical company priced its IPO at $18 per share and opened at $21. Latigo focuses on non-opioid pain medicines, and its lead asset LTG-001 for acute pain demonstrated 50%
-
Latigo Biotherapeutics (LTGO) completes IPO, raising nearly $350 million, with its non-opioid pain drug LTG-001 showing 50% greater relief than hydrocodone in trials.
The clinical-stage biopharmaceutical company priced its IPO at $18 per share and opened at $21. Latigo focuses on non-opioid pain medicines, and its lead asset LTG-001 for acute pain demonstrated 50%
- No data
Latigo Biotherapeutics
Svmuu provides news and information related to Latigo Biotherapeutics, as well as real-time data on Latigo Biotherapeutics. We provide in-depth analysis and interpretation of the latest Latigo Biotherapeutics developments, helping investors stay informed about Latigo Biotherapeutics policy updates. Svmuu is your essential tool for keeping up with the latest Latigo Biotherapeutics trends! Here, we’ll join you in keeping a close eye on Latigo Biotherapeutics news and use a clear macro perspective to make sense of the uncertain future of crypto.
24H Trending
-
1
Ukrainian Drones "Defeat" US Forces in German Military Exercise, Effectively Destroying a US Armored Brigade
-
2
Cream Finance: Offered a bug bounty to an attacker after a flash loan attack in 2021.
-
3
White House: President Donald Trump signed a National Security Presidential Memorandum authorizing federal law enforcement to use cyber tools to combat transnational cybercrime
-
4
Donald Trump Announces “Complete & Total Endorsement” of John Rutherford for Reelection in Florida’s 5th Congressional District
-
5
SpaceX Passes First Lockup Expiry Test With $500 Billion Rally, Easing Wall Street's Concerns Over Potential Flood of Shares After Aug. 6 Expiry
-
6
US Mortgage Rates Mixed on August 13: 30-Year Fixed Falls to 6.58%, 5/1 ARM Drops to 6.31% Amid Continued Volatility
-
7
Brazil's largest Bitcoin treasury firm OranjeBTC plans Digital Yield ETF (DIGY11) with 95% allocation to Strategy's STRC
-
8
US tech giants issue massive debt to fund AI, unexpectedly pushing up credit risk for "safest companies" with no AI connection
-
9
SK Hynix is investing $720 billion in South Korea to build the world's largest network of memory factories, aiming to meet surging AI demand.
-
10
US government debt nears $40 trillion, with this year's deficit projected at $1.887 trillion and interest payments expected to hit $1.1 trillion.
Markets Today
Recommended Reading

